RT Journal Article SR Electronic T1 New fluoroquinolone antibiotics JF Drug and Therapeutics Bulletin JO Drug Ther Bull FD BMJ Publishing Group Ltd SP 6 OP 8 DO 10.1136/dtb.1999.3716 VO 37 IS 1 YR 1999 UL http://dtb.bmj.com/content/37/1/6.abstract AB Relevant BNF section: 5.1.12In 1993, we reviewed three fluoroquinolone antibiotics (ciprofloxacin, norfloxacin and ofloxacin).1 Since then, four more fluoroquinolones have been awarded marketing authorisations. Here we review the clinical evidence and discuss the place of two of these drugs, â–¼grepafloxacin (Raxar - GlaxoWellcome) and â–¼levofloxacin (Tavanic - Hoechst Marion Roussel). Sparfloxacin and trovafloxacin are not considered, as they are not yet commercially available.